The Interstitial Lung Diseases: From Pathogenesis to Therapy
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Cell Biology and Pathology".
Deadline for manuscript submissions: closed (30 April 2023) | Viewed by 5733
Special Issue Editors
Interests: occupational diseases; lung function; respiratory physiology
Special Issue Information
Dear Colleagues,
According to its location, the interstitial space of the lung is classified as axial (peribronchovascular), parenchymal (alveolar), or peripheral (subpleural). These three compartments of support tissue communicate and create the milieu for the development of a heterogeneous group of distinct diseases that affect the lung via inflammation and fibrosis. The pathologies of the interstitium share several common clinical, radiological, and functional features.
The classification of interstitial lung diseases (ILDs) continues to evolve, but even with modern diagnosis techniques, some ILDs remain unclassifiable. On the other hand, many diseases which are not classified as ILDs (such as tuberculosis or COPD) have an interstitial component, which should receive further study so that appropriate treatment can be developed.
Recent advances in diagnosis and therapy have led to improved treatment, but only a comprehensive characterisation of the interstitial pathology, including etiological factors, biomarkers, phenotypes, and treatable traits, will allow for the introduction of precision medicine interventions.
We invite colleagues with an interest in this field of research to submit original research or review articles that contribute to the current body of knowledge on interstitial pathology, focusing in a broader sense on the pathogenic mechanisms that alter the interstitium. In this way, we hope to enhance the current understanding of the environmental and immunological factors of disease development and progression and the therapeutical approach.
Dr. Marina Ruxandra Otelea
Dr. Oana Cristina Arghir
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
